Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2011

01-02-2011 | Erratum

Erratum to: Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors

Authors: Anita L. Bane, Dushanthi Pinnaduwage, Sarah Colby, Michael Reedijk, Sean E. Egan, Shelley B. Bull, Frances P. O’Malley, Irene L. Andrulis

Published in: Breast Cancer Research and Treatment | Issue 1/2011

Login to get access

Excerpt

Author would like to add the two authors Michael Reedijk and Sean E. Egan to this work and their affiliations are given below. …
Metadata
Title
Erratum to: Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors
Authors
Anita L. Bane
Dushanthi Pinnaduwage
Sarah Colby
Michael Reedijk
Sean E. Egan
Shelley B. Bull
Frances P. O’Malley
Irene L. Andrulis
Publication date
01-02-2011
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2011
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-009-0563-2

Other articles of this Issue 1/2011

Breast Cancer Research and Treatment 1/2011 Go to the issue

Preclinical study

Role of ferritin alterations in human breast cancer cells

Preclinical study

Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients

Letter to the Editor

A small number of subjects do not always indicate that they are minor variants data for inclusion in a pooled analysis

Brief Report

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

Brief Report

Invasive ductal breast cancer associated polymyositis causing respiratory failure

Epidemiology

Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits